Risk Factors for Mortality Among Individuals With Peripheral Arterial Disease

American Journal of Cardiology

Volumn 120, Issue 5, 2017, Pages 862-867

  Amrock, Stephen M ^a   Abraham, Cherrie Z ^a   Jung, Enjae ^a   Morris, Pamela B ^b   Shapiro, Michael D ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MORTALITY RISK; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; AGED; CAUSE OF DEATH; CLINICAL TRIAL; DOPPLER ULTRASONOGRAPHY; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NUTRITION; PERIPHERAL ARTERIAL DISEASE; PROCEDURES; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TIME FACTOR; TRENDS; UNITED STATES;

ADULT; AGED; ANKLE BRACHIAL INDEX; CAUSE OF DEATH; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NUTRITION SURVEYS; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER; UNITED STATES;

EID: 85024473790     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2017.05.057     Document Type: Article

References (30)

1. Sampson, U.K., Fowkes, F.G., McDermott, M.M., Criqui, M.H., Aboyans, V., Norman, P.E., Forouzanfar, M.H., Naghavi, M., Song, Y., Harrell, F.E. Jr, Denenberg, J.O., Mensah, G.A., Ezzati, M., Murray, C., Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010. Glob Heart 9 (2014), 145–158 e121.
2. Haugen, S., Casserly, I.P., Regensteiner, J.G., Hiatt, W.R., Risk assessment in the patient with established peripheral arterial disease. Vasc Med 12 (2007), 343–350.
3. Fowkes, F.G., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J.O., McDermott, M.M., Norman, P.E., Sampson, U.K., Williams, L.J., Mensah, G.A., Criqui, M.H., Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382 (2013), 1329–1340.
4. Kullo, I.J., Rooke, T.W., Clinical practice. Peripheral artery disease. N Engl J Med 374 (2016), 861–871.
5. Zipf, G., Chiappa, M., Porter, K.S., Ostchega, Y., Lewis, B.G., Dostal, J., National Health and Nutrition Examination Survey: plan and operations, 1999–2010. Vital Health Stat 1, 2013, 1–37.
6. Honaker, J., King, G., Blackwell, M., Amelia, I.I., A program for missing data. J Stat Softw 45 (2011), 1–47.
7. Jha, P., Peto, R., Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med 370 (2014), 60–68.
8. Eisenberg, M.J., Windle, S.B., Roy, N., Old, W., Grondin, F.R., Bata, I., Iskander, A., Lauzon, C., Srivastava, N., Clarke, A., Cassavar, D., Dion, D., Haught, H., Mehta, S.R., Baril, J.F., Lambert, C., Madan, M., Abramson, B.L., Dehghani, P., Investigators, E., Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome. Circulation 133 (2016), 21–30.
9. Conen, D., Everett, B.M., Kurth, T., Creager, M.A., Buring, J.E., Ridker, P.M., Pradhan, A.D., Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med 154 (2011), 719–726.
10. Jonason, T., Bergstrom, R., Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 221 (1987), 253–260.
11. Al-Delaimy, W.K., Merchant, A.T., Rimm, E.B., Willett, W.C., Stampfer, M.J., Hu, F.B., Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men. Am J Med 116 (2004), 236–240.
12. Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O.E., Woerle, H.J., Broedl, U.C., Inzucchi, S.E., Investigators, E.-R.O., Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373 (2015), 2117–2128.
13. Chilton, R., Tikkanen, I., Cannon, C.P., Crowe, S., Woerle, H.J., Broedl, U.C., Johansen, O.E., Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes. Diabetes Obes Metab 17 (2015), 1180–1193.
14. Diehm, C., Lange, S., Darius, H., Pittrow, D., von Stritzky, B., Tepohl, G., Haberl, R.L., Allenberg, J.R., Dasch, B., Trampisch, H.J., Association of low ankle brachial index with high mortality in primary care. Eur Heart J 27 (2006), 1743–1749.
15. McDermott, M.M., Feinglass, J., Slavensky, R., Pearce, W.H., The ankle-brachial index as a predictor of survival in patients with peripheral vascular disease. J Gen Intern Med 9 (1994), 445–449.
16. O'Hare, A.M., Katz, R., Shlipak, M.G., Cushman, M., Newman, A.B., Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 113 (2006), 388–393.
17. Klein, A.J., Ross, C.B., Endovascular treatment of lower extremity peripheral arterial disease. Trends Cardiovasc Med 26 (2016), 495–512.
18. Pande, R.L., Perlstein, T.S., Beckman, J.A., Creager, M.A., Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004. Circulation 118 (2008), 33–41.
19. Mueller, T., Hinterreiter, F., Luft, C., Poelz, W., Haltmayer, M., Dieplinger, B., Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg 59 (2014), 1291–1299.
20. Amrock, S.M., Weitzman, M., Multiple biomarkers for mortality prediction in peripheral arterial disease. Vasc Med 21 (2016), 105–112.
21. Vos, E., Mascitelli, L., Rose, C.P., Regarding “does simvastatin save lives; if so, when and in whom?”. J Vasc Surg 47 (2008), 900–901 author reply 901.
22. Mohler, E.R. 3rd, Hiatt, W.R., Creager, M.A., Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 108 (2003), 1481–1486.
23. Pedersen, T.R., Kjekshus, J., Pyorala, K., Olsson, A.G., Cook, T.J., Musliner, T.A., Tobert, J.A., Haghfelt, T., Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol 81 (1998), 333–335.
24. Heart Protection Study Collaborative G, Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 45 (2007), 645–654 discussion 653-644.
25. Palmer, S.C., Navaneethan, S.D., Craig, J.C., Johnson, D.W., Perkovic, V., Nigwekar, S.U., Hegbrant, J., Strippoli, G.F., HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Libr(9), 2013 CD004289.
26. Lane, R., Ellis, B., Watson, L., Leng, G.C., Exercise for intermittent claudication. Cochrane Database of Systematic Review(7), 2014 CD000990.
27. Murphy, T.P., Cutlip, D.E., Regensteiner, J.G., Mohler, E.R. 3rd, Cohen, D.J., Reynolds, M.R., Massaro, J.M., Lewis, B.A., Cerezo, J., Oldenburg, N.C., Thum, C.C., Jaff, M.R., Comerota, A.J., Steffes, M.W., Abrahamsen, I.H., Goldberg, S., Hirsch, A.T., Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol 65 (2015), 999–1009.
28. Garg, P.K., Tian, L., Criqui, M.H., Liu, K., Ferrucci, L., Guralnik, J.M., Tan, J., McDermott, M.M., Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation 114 (2006), 242–248.
29. Gardner, A.W., Montgomery, P.S., Parker, D.E., Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg 47 (2008), 117–122.
30. Hamburg, N.M., Balady, G.J., Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits. Circulation 123 (2011), 87–97.